Researchers are piloting a new drug development pathway for the treatment of multiple sclerosis, asthma
There are benefits to delaying second doses of COVID-19 vaccines, but long-term outcomes depend on strong immunity
A single dose of the SARS-CoV-2 vaccine candidate stimulates a neutralization response in COVID-19 convalescents